临床医学专业是一门实践性很强的应用科学专业,致力于培养具备基础医学、临床医学的基本理论和医疗预防的基本技能;能在医疗卫生单位、医学科研等部门从事医疗及预防、医学科研等方面工作的医学高级专门人才。本文以临床医学硕士论文为例,为大家精选优秀临床医学硕士论文6篇,供大家参考学习。
第一篇 临床医学硕士论文 标题:冠状动脉介入手术术后采用益气活血方的疗效
本篇文章目录导航:
【题目】冠状动脉介入手术术后采用益气活血方的疗效
【前言-第一章】益气活血方在冠心病术后应用临床资料
【第二章】冠心病PIC术后中医治疗研究方法
【第三章】PIC手术患者服用益气活血方的效果研究结果
【第四章】益气活血方的有效性讨论
【第五章-参考文献】心脏支架手术患者中药疗效研究结语与参考文献
【综述1】冠心病及PCI术后中西医结合研究进展
【综述2】李应东教授治疗冠心病经验简述
中 文 摘 要
目的:观察益气活血方在常规西药基础上治疗冠心病 PCI 术后气虚血瘀证患者临床疗效及安全性,探索出中医药治疗 PCI 术后气虚血瘀证的有效方药,并优化辨证用药。
方法:本研究选自 2017 年 1 月-2018 年 1 月就诊于甘肃中医药大学附属医院心内科专家门诊的 140 例符合诊断标准的 PCI 术后气虚血瘀证患者作为研究对象,随机分为对照组和观察组。对照组常规西药治疗,观察组在对照组的治疗基础上服用益气活血方治疗 15 天。观察两组患者治疗前后中医证候疗效、心绞痛疗效、硝酸甘油减停率、心电图疗效、低密度脂蛋白、左室射血分数、6 分钟步行试验、欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分的改善情况,并用 SPSS23.0 软件进行分析数据,计数资料用卡方检验,计量资料以均数±标准差(`X2±S)表示,采用 t 检验,等级资料用秩和检验,以评估益气活血方治疗 PCI 术后气虚血瘀证的临床疗效。
结果:⑴中医证候疗效:治疗后观察组总有效率 80.6%,对照组为 29.4%,两组间比较有显着统计学意义(P<0.001);⑵心绞痛疗效:治疗后观察组总有效率 81.9%,对照组为 55.9%,其差异有显着统计学意义(P<0.01);⑶硝酸甘油减停率:治疗后观察组总有效率 88.9%,对照组总有效率 66.2%,组间比较有显着统计学意义(P<0.01);⑷心电图疗效:治疗后观察组总有效率 72.2.%,对照组总有效率 50%,其差异有统计学意义(P<0.05);⑸对 LDL-c 的影响:治疗后观察组与对照组无差异(P>0.05);⑹对左室射血分数(LVEF)的影响:治疗后观察组与对照组 LVEF 改善有显着性差异(P<0.001);⑺对 6 分钟步行试验的影响:治疗后观察组与对照组之间比较无统计学意义(P>0.05);⑻对欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分的影响:治疗后观察组与对照组有显着统计学意义(P<0.001)。
结论:本研究应用益气活血方,不仅显着改善患者气虚血瘀证的中医证候、缓解心绞痛、提高硝酸甘油减停率、改善心电图疗效,能够提高 LVEF、提高欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分,但对 LDL-c 和 6MWD 无显着改善、总体疗效确切,且未发现不良反应。
关键词:PCI 术后,益气活血方,气虚血瘀证,疗效观察
Abstract
Purpose: To observe the clinical efficacy and safety of Yiqi Huoxue Prescription in the treatment of coronary heart disease patients with qi deficiency and blood stasis syndrome on the basis of conventional western medicine, explore the effective prescriptions of Chinese medicine for the treatment of Qi deficiency and blood stasis syndrome after PCI, and optimize the use of syndrome differentiation drugs.
Method: This study was selected from 140 patients with qi deficiency and blood stasis syndrome who met the diagnostic criteria in the outpatient department of cardiology at the Affiliated Hospital of Gansu University of Traditional Chinese Medicine from January 2017 to January 2018. They were randomly divided into control group and Observation group. The control group was treated with conventional Western medicine, and the observation group was treated with Yiqi Huoxue Prescription on the basis of the treatment of the control group for 15 days.
Observe the efficacy of TCM syndrome before and after treatment, the effect of angina pectoris, the reduction of nitroglycerin, ECG efficacy, low-density lipoprotein, left ventricular ejection fraction, 6-minute walking test, and European V dimension health scale visual analogue scale (EQ-VAS) ) Improvements in scores were analyzed using SPSS 23.0 software. Chi-square test was performed on the count data. Measured data were expressed as mean ±standard deviation (X2±S). The t-test was used. Rank data were used for the rank sum test to evaluate Clinical Effect of Yiqi Huoxue Prescription in Treating Qi Deficiency and Blood Stasis Syndrome after PCI.
Result: (1) Efficacy of TCM syndromes: The total effective rate of the observation group after treatment was 80.6%, and that of the control group was 29.4%. There was statistically significant difference between the two groups (P<0.001); (2) Angina pectoris efficacy: The total effective rate of the observation group after treatment was 81.9% The control group was 55.9%, and the difference was statistically significant (P<0.01). (3) The nitroglycerin reduction rate: The total effective rate was 88.9% in the observation group and 66.2% in the control group after treatment. There was a significant difference between the groups. Statistical significance (P<0.01);4) Efficacy of ECG: The total effective rate of the observation group after treatment was 72.2%,and the total effective rate of the control group was 50%. The difference was statisticall ysignificant (P<0.05); (5) The LDL-c Effects: There was no difference between the observation group and the control group after treatment (P>0.05); (6) Effect on left ventricular ejection fraction (LVEF): There was a significant difference in improvement of LVEF between the observation group and the control group after treatment (P<0.001); (7) Effects on the 6-minute walking test: There was no significant difference between the observation group and the control group after treatment (P>0.05); (8) Effect on the EQ-VAS score of the European Five-Dimensional Health Scale: observation group and control group after treatment There was significant statistical significance (P<0.001).
Conclusions: The use of Yiqi Huoxue Prescription in this study not only significantly improve the TCM syndromes of patients with qi deficiency and blood stasis syndrome, relieve angina pectoris, increase the rate of nitroglycerin reduction, improve the efficacy of electrocardiogram, improve LVEF, and increase the visual analogue scale of European five-dimensional health scale. (EQ-VAS) score, but no significant improvement in LDL-c and 6MWD, the overall efficacy was definite, and no adverse reactions were found.
Key words: Postoperative PCI, Yiqi Huoxue Prescription, Qi Deficiency and Blood Stasis Syndrome, Observation of Curative Effect
目 录
中 文 摘 要
ABSTRACT
英文缩略词表
前 言
第一章 临床资料
1.1 一般资料
1.2 病例纳入标准
1.3 冠心病 PCI 术后中医证候诊断标准
1.4 病例排除标准
1.5 病例剔除及脱落标准
1.6 终止试验标准
第二章 研究方法
2.1 药品
2.2 分组与治法
2.3 观察指标
2.4 疗效判定标准
2.5 统计方法
第三章 结果
3.1 一般资料:年龄,性别、体重指数
3.2 两组患者中医证候疗效比较
3.3 两组患者心绞痛疗效比较
3.4 两组患者硝酸甘油减停率比较
3.5 两组患者心电图疗效比较
3.6 两组患者治疗前后低密度脂蛋白(LDL-C)比较
3.7 两组患者治疗前后左室射血分数(LVEF)比较
3.8 两组患者治疗前后 6 分钟步行试验(6MWT)结果比较
3.9 两组患者治疗前后欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分比较
3.10 安全性检测及不良反应
第四章 讨论
4.1 PCI 术及其中医认识
4.2 益气活血方来源及方解
4.3 益气活血方对 PCI 术后患者的疗效
第五章 结语
5.1 结论
5.2 不足与展望
参考文献
综 述
冠心病及 PCI 术后中西医结合研究进展
1. 冠心病的西医认识
1.1 冠心病概述
1.2 危险因素
1.3 发病机制
1.4 预防
1.5 治疗
1.6 PCI 术目前治疗现状及困惑
2. 冠心病中医认识及 PCI 术后中医诊疗进展
2.1 病名
2.2 病因认识
2.3 病机认识
2.4 治法历史沿革
2.5 冠心病 PCI 术后病因病机
2.6 益气活血法治疗 PCI 术后研究进展
3. 结语
李应东教授治疗冠心病经验简述
1. 注重治未病
2. 整体观视野下辨治冠心病
3. 中西医结合,辨病、辨证、辨体质结合
4. 阴阳气血同调
5. 身心同治
6. 从脾肾论治冠心病
参考文献
附 表
附表 1.知情同意书
附表 2.受试者基本信息调查表
附表 3.中医证候积分表
附表 4.心绞痛积分表
附表 5.EQ-VAS
在学期间的研究成果
致 谢
TAG标签: 临床医学硕士